InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Smith Mark Douglas, Director. Insider active across 3 companies, notably Teladoc Health, Inc.. Cumulatively, 20 disclosures have been logged. Split: 1 buy · 3 sells. Total volume traded: €178k. History available since 8 July 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Smith Mark Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
1,605 shares0Ordinary SharesSEC:0001756253-26-000006:0
3,507 shares0Ordinary SharesSEC:0001765581-25-000080:0
7,000 shares@ US$4.7111.3% of flowCommon StockSEC:0001127602-25-018936:0
6,700 shares@ US$27.6172.4% of flowCommon StockSEC:0001127602-25-018206:0
4,000 shares@ US$7.078100.0% of flowCommon StockSEC:0001628280-24-037693:0
Canonical exit: 13 Nov 2024 (T+90)
3,731 shares0Ordinary SharesSEC:0001765581-24-000078:0
7,000 shares@ US$4.7150.0% of flowCommon StockSEC:0001127602-24-020800:0
8,490 shares0Common StockSEC:0001127602-24-019403:0
417 shares@ US$119.2723.2% of flowOrdinary SharesSEC:0001765581-23-000110:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000090:0
6,051 shares0Common StockSEC:0001562180-23-005580:0
7,000 shares@ US$4.7150.0% of flowCommon StockSEC:0001562180-23-003442:0
420 shares@ US$154.680631.4% of flowOrdinary SharesSEC:0001765581-22-000130:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000098:0
7,397 shares0Common StockSEC:0001562180-22-005519:0
819 sharesCommon StockSEC:0001415889-22-005235:0
417 shares@ US$121.3029.4% of flowOrdinary SharesSEC:0001765581-21-000133:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000083:0
2,605 shares0Common StockSEC:0001562180-21-004894:0
524 sharesCommon StockSEC:0001179110-21-005495:0
20 of 20 declarations
About Smith Mark Douglas
Smith Mark Douglas is Administrateur at Jazz Pharmaceuticals plc, Phreesia, Inc. and Teladoc Health, Inc. Across 19 filings in total, the 19 sampled filings run from 2021-05-18 to 2025-08-11 and show EUR 25802 of buys and EUR 152070 of sells, with the dominant transaction nature listed as Attribution.
